Trial
NCT00123539
Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
UnknownTERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborators
—
Condition
Coronary Disease
Intervention
Estrogen Replacement Therapy
Why stopped
DSMB stopped the study based on conclusion of likely futility of treatment on the primary outcome.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-07-29